721 - 730 of 8436 Results
Title
Year
-
OPENTitle: Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domainsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12461Best OA location URL: https://doi.org/10.1002/trc2.12461Citation Count: 12
-
OPENTitle: Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page: 1096End Page: 1103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-02886-yBest OA location URL: https://www.nature.com/articles/s41591-024-02886-y.pdfCitation Count: 22
-
OPENTitle: Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohortJournal Name: Autonomic NeurosciencePublisher: Elsevier BVVol: 253Issue #:Start Page: 103173End Page: 103173Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.autneu.2024.103173Best OA location URL: https://www.medrxiv.org/content/medrxiv/early/2023/10/17/2023.10.16.23297107.full.pdfCitation Count: 4
-
OPENTitle: The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystoniaJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 134Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci177833Best OA location URL: https://doi.org/10.1172/jci177833Citation Count: 6
-
OPENTitle: Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00685-3Best OA location URL: https://www.nature.com/articles/s41531-024-00685-3.pdfCitation Count: 11
-
OPENTitle: Genotype–phenotype correlation in PRKN-associated Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00677-3Best OA location URL: https://www.nature.com/articles/s41531-024-00677-3.pdfCitation Count: 26
-
OPENTitle: Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-46832-5Best OA location URL: https://www.nature.com/articles/s41467-024-46832-5.pdfCitation Count: 30
-
OPENTitle: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification AssayJournal Name: Annals of NeurologyPublisher: WileyVol: 95Issue #: 6Start Page: 1173End Page: 1177Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26917Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26917Citation Count: 12
-
OPENTitle: Development and characterization of a non-human primate model of disseminated synucleinopathyJournal Name: Frontiers in NeuroanatomyPublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnana.2024.1355940Best OA location URL: https://doi.org/10.3389/fnana.2024.1355940Citation Count: 2
-
RESTRICTEDTitle: Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's diseaseJournal Name:Publisher: Cold Spring Harbor LaboratoryVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1101/2024.03.22.586364Citation Count: